68Ga-labelled prostate-specific membrane antigen (PSMA) is emerging as the tool with the
most potential for imaging recurrent prostate cancer [1]. There have been a few reports of …

68Ga-labeled prostate-specific membrane antigen (PSMA), a PET tracer that was recently
introduced for the imaging of prostate cancer, may accumulate in other solid tumors …

Abstract 68 Ga-PSMA based integrated PET/MRI is emerging as a novel imaging technique
for the staging of prostate carcinoma. We report a case of a 77-year-old man with raised …

68Ga-labelled prostate-specific membrane antigen (PSMA) is rapidly emerging as a
significant step forward in the diagnosis of recurrent prostate cancer, based on the fact that …

Prostate-specific membrane antigen (PSMA) is a type II transmembrane protein with high
expression in prostate carcinoma cells. Glu-NH-CO-NH-Lys-(Ahx)-[68Ga (HBED-CC)](68Ga …

Purpose Prostate-specific membrane antigen (PSMA) is not only highly expressed on the
surface prostate cancer cells but is also elevated during angiogenesis in other cancer cell …

The potential applications of 68 Ga-labeled prostate-specific membrane antigen (PSMA)
PET/CT in the imaging of prostate cancer are now well established. A few case reports …

PET/CT with 68 Ga-labeled prostate-specific membrane antigen (PSMA) is increasingly
recognized as the best imaging modality for disease staging and detection of recurrent …

Materials and Methods Nineteen HCC patients who underwent 18 F-fluorodeoxyglucose (18
F-FDG) positron emission tomography (PET) as part of restaging procedure also underwent …

Prostate-specific membrane antigen (PSMA) is a cell surface protein, which is expressed at
higher levels in prostate cancer compared to other tissues. This protein provides a promising …